http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
-
EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
-
Real-World Evidence Confirms High Effectiveness of Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
-
Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
-
Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
-
Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
-
Pfizer (PFE), BioNTech (BNTX) Initiate Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
-
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
-
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
-
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
-
Pfizer (PFE) and BioNTech (BNTX) Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
-
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
-
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
-
Pfizer (PFE), BioNTech (BNTX) Starts Trial to Evaluate COVID-19 Vaccine in Pregnant Women
-
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
-
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
-
In Vitro Study Published in NEJM Demonstrates Sera from Individuals Immunized with the Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
-
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant
-
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant
-
Pfizer (PFE) and BioNTech (BNTX) to Supply European Union with 200 Million Additional Doses of COVID-19 Vaccine
-
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
-
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
-
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
-
Pfizer (PFE), BioNTech (BNTX) to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer (PFE) and BioNTech (BNTX) Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
-
Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
-
Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
-
Pfizer (PFE), BioNTech (BNTX) Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
-
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
-
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
-
Pfizer (PFE), BioNTech (BNTX) Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
-
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
-
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
-
Pfizer (PFE), BioNTech SE (BNTX) Study Shows its COVID-19 Vaccine Works on More Contagious U.K. Strain
-
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
-
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
-
Pfizer (PFE), BioNTech (BNTX) to Supply the European Union with 100 Million Additional COVID-19 Vaccine Doses
-
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
-
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
-
Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer (PFE), BioNTech (BNTX) to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
-
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
-
Pfizer (PFE), BioNTech (BNTX) Confirm Authorization in the European Union for COVID-19 Vaccine
-
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
-
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
-
Pfizer (PFE) and BioNTech (BNTX) Confirm CHMP Positive Opinion for their COVID-19 Vaccine

